Bright Minds Biosciences Inc. (NASDAQ:DRUG) went down by -5.33% from its latest closing price compared to the recent 1-year high of $8.95. The company’s stock price has collected -13.41% of loss in the last five trading sessions.
Is It Worth Investing in Bright Minds Biosciences Inc. (NASDAQ :DRUG) Right Now?
Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Bright Minds Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $9.09, which is -$0.41 below the current price. DRUG currently public float of 6.79M and currently shorts hold a 0.48% ratio of that float. Today, the average trading volume of DRUG was 12.09M shares.
DRUG’s Market Performance
DRUG stocks went down by -13.41% for the week, with a monthly drop of -34.56% and a quarterly performance of 65.02%, while its annual performance rate touched -76.37%. The volatility ratio for the week stands at 16.04% while the volatility levels for the past 30 days are set at 36.78% for Bright Minds Biosciences Inc. The simple moving average for the period of the last 20 days is -23.24% for DRUG stocks with a simple moving average of -19.60% for the last 200 days.
DRUG Trading at 6.55% from the 50-Day Moving Average
After a stumble in the market that brought DRUG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.13% of loss for the given period.
Volatility was left at 36.78%, however, over the last 30 days, the volatility rate increased by 16.04%, as shares surge +13.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +50.44% upper at present.
During the last 5 trading sessions, DRUG fell by -13.41%, which changed the moving average for the period of 200-days by -63.21% in comparison to the 20-day moving average, which settled at $1.8585. In addition, Bright Minds Biosciences Inc. saw -55.21% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for DRUG
Equity return is now at value -111.10, with -106.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 31.38.